SCORR Marketing and ACT Conduct Survey on Paperless Processes
SCORR Marketing, in partnership with Applied Clinical Trials, has released the results of a survey on the use of paperless processes in clinical trials.
SCORR Marketing, in partnership with Applied Clinical Trials, has released the results of a survey on the use of paperless processes in clinical trials. The report describes the implementations, benefits, challenges and future of such processes.
Read the full release here
Key Phase 3 Trial Results Lead to FDA Approval of Fabhalta for Paroxysmal Nocturnal Hemoglobinuria
December 6th 2023Clinical trials demonstrated superiority of Fabhalta to anti-C5s in hemoglobin improvement in the absence of transfusions and transfusion avoidance rate, showing clinically meaningful hemoglobin-level increases without the need for blood transfusions in patients with paroxysmal nocturnal hemoglobinuria.
‘Hypothesis-Free’: Getting Proactive About Signal Detection
December 5th 2023Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.
